Buprenorphine vs Pembrolizumab
Buprenorphine vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Buprenorphine and Pembrolizumab.
Mechanism of Action
Buprenorphine: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Buprenorphine — 24-42 hours; Pembrolizumab — 26 days.
Chemical Properties
Molecular Formula: Buprenorphine — C29H41NO4.
Molecular Weight: Buprenorphine — 467.6430 g/mol.
Type: Buprenorphine — Small molecule; Pembrolizumab — Antibody.